Clinical Trial Update: Triheptanoin in Mc Ardle [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 study of triheptanoin for Glycogen Storage Disease Type V (McArdle disease) in France.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glycogen Storage Disease Type

Drugs mentioned

• Triheptanoin (triheptanoin)

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Glycogen Storage Disease Type V | Phase 2 | Status: COMPLETED